Marc de Garidel, CEO Abivax, Take risks to build something meaningful cover
Marc de Garidel, CEO Abivax, Take risks to build something meaningful cover
Pharma minds

Marc de Garidel, CEO Abivax, Take risks to build something meaningful

Marc de Garidel, CEO Abivax, Take risks to build something meaningful

1h10 |20/11/2023
Play
Marc de Garidel, CEO Abivax, Take risks to build something meaningful cover
Marc de Garidel, CEO Abivax, Take risks to build something meaningful cover
Pharma minds

Marc de Garidel, CEO Abivax, Take risks to build something meaningful

Marc de Garidel, CEO Abivax, Take risks to build something meaningful

1h10 |20/11/2023
Play

Description

In the fascinating world of Pharma, a visionary and pragmatic man, @Marc de Garidel, stands out. His journey began in a down-to-earth family, setting the stage for an extraordinary adventure.


ūüĆć Careers are rarely planned, but his appetite for adventure emerged early:

  • He launched Amgen in Europe.
  • He developed Ipsen in the United States.

These initial steps marked the commencement of an incredible journey in the pharmaceutical world, teaching him how Pharma truly operates, especially regarding access today.


ūüöÄ Then, he embarked on a more entrepreneurial path as the CEO of biotechs:

  • Corvidia Therapeutics, sold to Novo Nordisk in August 2020.
  • CinCor Pharma, sold to AstraZeneca in February 2023.
  • Currently, he is the CEO of Abivax.

This experience taught him that taking risks fuels innovation, and every failure is a step towards success.


ūüĆü Today, as the CEO of Abivax, Marc shares his wealth of experience with the Pharma community. His story is an invitation to embrace the unknown, confront challenges with courage, and see every opportunity as a new adventure.


Marc encourages bold minds to pursue their passions, dare to take risks, and view every obstacle as a step towards success.


Marc is a passionate individual, a grounded soul unafraid to dream big for patients.


His legacy serves as a timeless reminder that adventure, wisdom, and courage constitute a potent trio for those aspiring to push the boundaries of medical innovation.


-

Update since the recording of the episode:

This interview took place in August. In October, Abivax entered the Nasdaq. Despite a challenging stock market context, this is the largest IPO in the history of a French biotech. ūüöĬ†


-


Notes and episode references


Links : 

Abivax : https://www.abivax.com/ 


The LinkedIn post if you want to share your feedback or ask questions:

https://www.linkedin.com/posts/nathalielahitte_in-the-fascinating-world-of-pharma-marc-activity-7132294793195352064-HKrE?utm_source=share&utm_medium=member_desktop 


-


1. Working together!


THE FARM & CO develops your visibility in Pharma using the strength of your therapeutic commitment, the uniqueness of your personality and the power of social networks. Build a presence aligned with your values. Ghostwriting, content creation & conversational tools.


2. My newsletter


In my newsletter Pharma futurista, 2x/month, I jump into our society's evolutions and apply them to the future of Pharma. It's a short, 3-minute read on a subject that appeals to me. To receive it, you can subscribe here: https://nathalielahitte.substack.com/  or directly on my LinkedIn profile.


3. Get in touch with me! 


If you like the podcast, the best way to tell me or share your thoughts is on the Apple podcast app. It really helps me out, so don't hesitate to share!


If you'd like to ask me questions or follow my progress, you can do so on LinkedIn @nathalie lahitte .


Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Chapters

  • Shorts

    00:01

  • Intro

    00:54

  • Hello Marc!

    01:35

  • Where does he come from?

    02:53

  • Starting with a diploma as a civil engineer

    04:42

  • Beginning a career in finance with Eli Lilly

    06:30

  • Entering the biotech world with Amgen

    07:20

  • The 1st important decision reveals he likes taking risk

    08:52

  • Anecdote related to his detail attention in the beginning

    10:01

  • From knowing the details to ask to the good questions

    12:17

  • Ask simple questions

    14:15

  • His 4 attributes of a good leader

    15:08

  • How he knew where he wanted to go

    17:35

  • His profound driver

    19:14

  • When he knew he wanted to be a CEO

    22:30

  • Important vs urgent decisions: launching in the US

    24:55

  • Change from Amgen now big, to Ipsen

    27:08

  • Do meaningful things for you

    29:37

  • The risk of failure helps you grow

    30:41

  • Don't make big mistakes

    32:08

  • His impatience

    33:36

  • From managing 5.000 people to 15 people

    34:18

  • The value of experience

    36:05

  • It' about getting a reimbursement

    37:36

  • Why CinCor has been sold

    38:15

  • Today's vision about access

    39:05

  • The key is differenciation

    41:06

  • His worries for access in Europe

    41:48

  • His learnings from biotech experiences

    46:30

  • 3 key areas for a biotech success

    48:17

  • Progressing: knowing where you are good at, or not

    51:28

  • Resilience as an important attribute

    53:30

  • The hight level of energy needed

    54:33

  • His way to deconnect and keep his discernment

    56:25

  • It happens to make errors

    59:34

  • Getting older and yet don't letting you fears drive you

    01:00:48

  • About dreams & doubts

    01:04:12

  • Success for him

    01:05:15

  • His next dream

    01:05:51

  • How he guides his kids

    01:06:47

  • His advices for Pharma collaborators

    01:08:26

Description

In the fascinating world of Pharma, a visionary and pragmatic man, @Marc de Garidel, stands out. His journey began in a down-to-earth family, setting the stage for an extraordinary adventure.


ūüĆć Careers are rarely planned, but his appetite for adventure emerged early:

  • He launched Amgen in Europe.
  • He developed Ipsen in the United States.

These initial steps marked the commencement of an incredible journey in the pharmaceutical world, teaching him how Pharma truly operates, especially regarding access today.


ūüöÄ Then, he embarked on a more entrepreneurial path as the CEO of biotechs:

  • Corvidia Therapeutics, sold to Novo Nordisk in August 2020.
  • CinCor Pharma, sold to AstraZeneca in February 2023.
  • Currently, he is the CEO of Abivax.

This experience taught him that taking risks fuels innovation, and every failure is a step towards success.


ūüĆü Today, as the CEO of Abivax, Marc shares his wealth of experience with the Pharma community. His story is an invitation to embrace the unknown, confront challenges with courage, and see every opportunity as a new adventure.


Marc encourages bold minds to pursue their passions, dare to take risks, and view every obstacle as a step towards success.


Marc is a passionate individual, a grounded soul unafraid to dream big for patients.


His legacy serves as a timeless reminder that adventure, wisdom, and courage constitute a potent trio for those aspiring to push the boundaries of medical innovation.


-

Update since the recording of the episode:

This interview took place in August. In October, Abivax entered the Nasdaq. Despite a challenging stock market context, this is the largest IPO in the history of a French biotech. ūüöĬ†


-


Notes and episode references


Links : 

Abivax : https://www.abivax.com/ 


The LinkedIn post if you want to share your feedback or ask questions:

https://www.linkedin.com/posts/nathalielahitte_in-the-fascinating-world-of-pharma-marc-activity-7132294793195352064-HKrE?utm_source=share&utm_medium=member_desktop 


-


1. Working together!


THE FARM & CO develops your visibility in Pharma using the strength of your therapeutic commitment, the uniqueness of your personality and the power of social networks. Build a presence aligned with your values. Ghostwriting, content creation & conversational tools.


2. My newsletter


In my newsletter Pharma futurista, 2x/month, I jump into our society's evolutions and apply them to the future of Pharma. It's a short, 3-minute read on a subject that appeals to me. To receive it, you can subscribe here: https://nathalielahitte.substack.com/  or directly on my LinkedIn profile.


3. Get in touch with me! 


If you like the podcast, the best way to tell me or share your thoughts is on the Apple podcast app. It really helps me out, so don't hesitate to share!


If you'd like to ask me questions or follow my progress, you can do so on LinkedIn @nathalie lahitte .


Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Chapters

  • Shorts

    00:01

  • Intro

    00:54

  • Hello Marc!

    01:35

  • Where does he come from?

    02:53

  • Starting with a diploma as a civil engineer

    04:42

  • Beginning a career in finance with Eli Lilly

    06:30

  • Entering the biotech world with Amgen

    07:20

  • The 1st important decision reveals he likes taking risk

    08:52

  • Anecdote related to his detail attention in the beginning

    10:01

  • From knowing the details to ask to the good questions

    12:17

  • Ask simple questions

    14:15

  • His 4 attributes of a good leader

    15:08

  • How he knew where he wanted to go

    17:35

  • His profound driver

    19:14

  • When he knew he wanted to be a CEO

    22:30

  • Important vs urgent decisions: launching in the US

    24:55

  • Change from Amgen now big, to Ipsen

    27:08

  • Do meaningful things for you

    29:37

  • The risk of failure helps you grow

    30:41

  • Don't make big mistakes

    32:08

  • His impatience

    33:36

  • From managing 5.000 people to 15 people

    34:18

  • The value of experience

    36:05

  • It' about getting a reimbursement

    37:36

  • Why CinCor has been sold

    38:15

  • Today's vision about access

    39:05

  • The key is differenciation

    41:06

  • His worries for access in Europe

    41:48

  • His learnings from biotech experiences

    46:30

  • 3 key areas for a biotech success

    48:17

  • Progressing: knowing where you are good at, or not

    51:28

  • Resilience as an important attribute

    53:30

  • The hight level of energy needed

    54:33

  • His way to deconnect and keep his discernment

    56:25

  • It happens to make errors

    59:34

  • Getting older and yet don't letting you fears drive you

    01:00:48

  • About dreams & doubts

    01:04:12

  • Success for him

    01:05:15

  • His next dream

    01:05:51

  • How he guides his kids

    01:06:47

  • His advices for Pharma collaborators

    01:08:26

Share

Embed

You may also like

Description

In the fascinating world of Pharma, a visionary and pragmatic man, @Marc de Garidel, stands out. His journey began in a down-to-earth family, setting the stage for an extraordinary adventure.


ūüĆć Careers are rarely planned, but his appetite for adventure emerged early:

  • He launched Amgen in Europe.
  • He developed Ipsen in the United States.

These initial steps marked the commencement of an incredible journey in the pharmaceutical world, teaching him how Pharma truly operates, especially regarding access today.


ūüöÄ Then, he embarked on a more entrepreneurial path as the CEO of biotechs:

  • Corvidia Therapeutics, sold to Novo Nordisk in August 2020.
  • CinCor Pharma, sold to AstraZeneca in February 2023.
  • Currently, he is the CEO of Abivax.

This experience taught him that taking risks fuels innovation, and every failure is a step towards success.


ūüĆü Today, as the CEO of Abivax, Marc shares his wealth of experience with the Pharma community. His story is an invitation to embrace the unknown, confront challenges with courage, and see every opportunity as a new adventure.


Marc encourages bold minds to pursue their passions, dare to take risks, and view every obstacle as a step towards success.


Marc is a passionate individual, a grounded soul unafraid to dream big for patients.


His legacy serves as a timeless reminder that adventure, wisdom, and courage constitute a potent trio for those aspiring to push the boundaries of medical innovation.


-

Update since the recording of the episode:

This interview took place in August. In October, Abivax entered the Nasdaq. Despite a challenging stock market context, this is the largest IPO in the history of a French biotech. ūüöĬ†


-


Notes and episode references


Links : 

Abivax : https://www.abivax.com/ 


The LinkedIn post if you want to share your feedback or ask questions:

https://www.linkedin.com/posts/nathalielahitte_in-the-fascinating-world-of-pharma-marc-activity-7132294793195352064-HKrE?utm_source=share&utm_medium=member_desktop 


-


1. Working together!


THE FARM & CO develops your visibility in Pharma using the strength of your therapeutic commitment, the uniqueness of your personality and the power of social networks. Build a presence aligned with your values. Ghostwriting, content creation & conversational tools.


2. My newsletter


In my newsletter Pharma futurista, 2x/month, I jump into our society's evolutions and apply them to the future of Pharma. It's a short, 3-minute read on a subject that appeals to me. To receive it, you can subscribe here: https://nathalielahitte.substack.com/  or directly on my LinkedIn profile.


3. Get in touch with me! 


If you like the podcast, the best way to tell me or share your thoughts is on the Apple podcast app. It really helps me out, so don't hesitate to share!


If you'd like to ask me questions or follow my progress, you can do so on LinkedIn @nathalie lahitte .


Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Chapters

  • Shorts

    00:01

  • Intro

    00:54

  • Hello Marc!

    01:35

  • Where does he come from?

    02:53

  • Starting with a diploma as a civil engineer

    04:42

  • Beginning a career in finance with Eli Lilly

    06:30

  • Entering the biotech world with Amgen

    07:20

  • The 1st important decision reveals he likes taking risk

    08:52

  • Anecdote related to his detail attention in the beginning

    10:01

  • From knowing the details to ask to the good questions

    12:17

  • Ask simple questions

    14:15

  • His 4 attributes of a good leader

    15:08

  • How he knew where he wanted to go

    17:35

  • His profound driver

    19:14

  • When he knew he wanted to be a CEO

    22:30

  • Important vs urgent decisions: launching in the US

    24:55

  • Change from Amgen now big, to Ipsen

    27:08

  • Do meaningful things for you

    29:37

  • The risk of failure helps you grow

    30:41

  • Don't make big mistakes

    32:08

  • His impatience

    33:36

  • From managing 5.000 people to 15 people

    34:18

  • The value of experience

    36:05

  • It' about getting a reimbursement

    37:36

  • Why CinCor has been sold

    38:15

  • Today's vision about access

    39:05

  • The key is differenciation

    41:06

  • His worries for access in Europe

    41:48

  • His learnings from biotech experiences

    46:30

  • 3 key areas for a biotech success

    48:17

  • Progressing: knowing where you are good at, or not

    51:28

  • Resilience as an important attribute

    53:30

  • The hight level of energy needed

    54:33

  • His way to deconnect and keep his discernment

    56:25

  • It happens to make errors

    59:34

  • Getting older and yet don't letting you fears drive you

    01:00:48

  • About dreams & doubts

    01:04:12

  • Success for him

    01:05:15

  • His next dream

    01:05:51

  • How he guides his kids

    01:06:47

  • His advices for Pharma collaborators

    01:08:26

Description

In the fascinating world of Pharma, a visionary and pragmatic man, @Marc de Garidel, stands out. His journey began in a down-to-earth family, setting the stage for an extraordinary adventure.


ūüĆć Careers are rarely planned, but his appetite for adventure emerged early:

  • He launched Amgen in Europe.
  • He developed Ipsen in the United States.

These initial steps marked the commencement of an incredible journey in the pharmaceutical world, teaching him how Pharma truly operates, especially regarding access today.


ūüöÄ Then, he embarked on a more entrepreneurial path as the CEO of biotechs:

  • Corvidia Therapeutics, sold to Novo Nordisk in August 2020.
  • CinCor Pharma, sold to AstraZeneca in February 2023.
  • Currently, he is the CEO of Abivax.

This experience taught him that taking risks fuels innovation, and every failure is a step towards success.


ūüĆü Today, as the CEO of Abivax, Marc shares his wealth of experience with the Pharma community. His story is an invitation to embrace the unknown, confront challenges with courage, and see every opportunity as a new adventure.


Marc encourages bold minds to pursue their passions, dare to take risks, and view every obstacle as a step towards success.


Marc is a passionate individual, a grounded soul unafraid to dream big for patients.


His legacy serves as a timeless reminder that adventure, wisdom, and courage constitute a potent trio for those aspiring to push the boundaries of medical innovation.


-

Update since the recording of the episode:

This interview took place in August. In October, Abivax entered the Nasdaq. Despite a challenging stock market context, this is the largest IPO in the history of a French biotech. ūüöĬ†


-


Notes and episode references


Links : 

Abivax : https://www.abivax.com/ 


The LinkedIn post if you want to share your feedback or ask questions:

https://www.linkedin.com/posts/nathalielahitte_in-the-fascinating-world-of-pharma-marc-activity-7132294793195352064-HKrE?utm_source=share&utm_medium=member_desktop 


-


1. Working together!


THE FARM & CO develops your visibility in Pharma using the strength of your therapeutic commitment, the uniqueness of your personality and the power of social networks. Build a presence aligned with your values. Ghostwriting, content creation & conversational tools.


2. My newsletter


In my newsletter Pharma futurista, 2x/month, I jump into our society's evolutions and apply them to the future of Pharma. It's a short, 3-minute read on a subject that appeals to me. To receive it, you can subscribe here: https://nathalielahitte.substack.com/  or directly on my LinkedIn profile.


3. Get in touch with me! 


If you like the podcast, the best way to tell me or share your thoughts is on the Apple podcast app. It really helps me out, so don't hesitate to share!


If you'd like to ask me questions or follow my progress, you can do so on LinkedIn @nathalie lahitte .


Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

Chapters

  • Shorts

    00:01

  • Intro

    00:54

  • Hello Marc!

    01:35

  • Where does he come from?

    02:53

  • Starting with a diploma as a civil engineer

    04:42

  • Beginning a career in finance with Eli Lilly

    06:30

  • Entering the biotech world with Amgen

    07:20

  • The 1st important decision reveals he likes taking risk

    08:52

  • Anecdote related to his detail attention in the beginning

    10:01

  • From knowing the details to ask to the good questions

    12:17

  • Ask simple questions

    14:15

  • His 4 attributes of a good leader

    15:08

  • How he knew where he wanted to go

    17:35

  • His profound driver

    19:14

  • When he knew he wanted to be a CEO

    22:30

  • Important vs urgent decisions: launching in the US

    24:55

  • Change from Amgen now big, to Ipsen

    27:08

  • Do meaningful things for you

    29:37

  • The risk of failure helps you grow

    30:41

  • Don't make big mistakes

    32:08

  • His impatience

    33:36

  • From managing 5.000 people to 15 people

    34:18

  • The value of experience

    36:05

  • It' about getting a reimbursement

    37:36

  • Why CinCor has been sold

    38:15

  • Today's vision about access

    39:05

  • The key is differenciation

    41:06

  • His worries for access in Europe

    41:48

  • His learnings from biotech experiences

    46:30

  • 3 key areas for a biotech success

    48:17

  • Progressing: knowing where you are good at, or not

    51:28

  • Resilience as an important attribute

    53:30

  • The hight level of energy needed

    54:33

  • His way to deconnect and keep his discernment

    56:25

  • It happens to make errors

    59:34

  • Getting older and yet don't letting you fears drive you

    01:00:48

  • About dreams & doubts

    01:04:12

  • Success for him

    01:05:15

  • His next dream

    01:05:51

  • How he guides his kids

    01:06:47

  • His advices for Pharma collaborators

    01:08:26

Share

Embed

You may also like